[English] 日本語
Yorodumi- PDB-8fhw: Cryo-EM structure of Cryptococcus neoformans trehalose-6-phosphat... -
+Open data
-Basic information
Entry | Database: PDB / ID: 8fhw | ||||||
---|---|---|---|---|---|---|---|
Title | Cryo-EM structure of Cryptococcus neoformans trehalose-6-phosphate synthase homotetramer in complex with uridine diphosphate and glucose-6-phosphate | ||||||
Components | Alpha,alpha-trehalose-phosphate synthase (UDP-forming)Alpha,alpha-trehalose-phosphate synthase (UDP-forming) | ||||||
Keywords | TRANSFERASE / Glycosyltransferase / Complex | ||||||
Function / homology | Glycosyl transferase, family 20 / Glycosyltransferase family 20 / trehalose biosynthetic process / hexosyltransferase activity / 6-O-phosphono-alpha-D-glucopyranose / URIDINE-5'-DIPHOSPHATE / Alpha,alpha-trehalose-phosphate synthase (UDP-forming) Function and homology information | ||||||
Biological species | Cryptococcus neoformans var. grubii H99 (fungus) | ||||||
Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3.2 Å | ||||||
Authors | Washington, E.J. / Brennan, R.G. | ||||||
Funding support | United States, 1items
| ||||||
Citation | Journal: bioRxiv / Year: 2023 Title: Structures of trehalose-6-phosphate synthase, Tps1, from the fungal pathogen : a target for novel antifungals. Authors: Erica J Washington / Ye Zhou / Allen L Hsu / Matthew Petrovich / Mario J Borgnia / Alberto Bartesaghi / Richard G Brennan / Abstract: Invasive fungal diseases are a major threat to human health, resulting in more than 1.5 million deaths worldwide each year. Yet the arsenal of antifungal therapeutics remains limited and is in dire ...Invasive fungal diseases are a major threat to human health, resulting in more than 1.5 million deaths worldwide each year. Yet the arsenal of antifungal therapeutics remains limited and is in dire need of novel drugs that target additional fungal-specific biosynthetic pathways. One such pathway involves the biosynthesis of trehalose. Trehalose is a non-reducing disaccharide composed of two molecules of glucose that is required for pathogenic fungi, including and , to survive in their human hosts. Trehalose biosynthesis is a two-step process in fungal pathogens. Trehalose-6-phosphate synthase (Tps1) converts UDP-glucose and glucose-6-phosphate to trehalose-6-phosphate (T6P). Subsequently, trehalose-6-phosphate phosphatase (Tps2) converts T6P to trehalose. The trehalose biosynthesis pathway has been identified as a top candidate for novel antifungal development based on quality, occurrence, specificity, and assay development. However, there are currently no known antifungal agents that target this pathway. As initial steps to develop Tps1 from (CnTps1) as a drug target, we report the structures of full-length CnTps1 and CnTps1 in complex with uridine diphosphate (UDP) and glucose-6-phosphate (G6P). Both CnTps1 structures are tetramers and display D2 (222) molecular symmetry. Comparison of these two structures reveals significant movement towards the catalytic pocket by the N-terminus upon ligand binding and identifies key residues required for substrate-binding, which are conserved amongst other Tps1 enzymes, as well as residues that stabilize the tetramer. Intriguingly, an intrinsically disordered domain (IDD), encompassing residues M209 to I300, which is conserved amongst Cryptococcal species and closely related Basidiomycetes, extends from each subunit of the tetramer into the "solvent" but is not visible in the density maps. Although, activity assays revealed that the highly conserved IDD is not required for catalysis , we hypothesize that the IDD is required for Tps1-dependent thermotolerance and osmotic stress survival. Characterization of the substrate specificity of CnTps1 revealed that UDP-galactose, an epimer of UDP-glucose, is a very poor substrate and inhibitor of the enzyme and highlights the exquisite substrate specificity of Tps1. , these studies expand our knowledge of trehalose biosynthesis in and highlight the potential of developing antifungal therapeutics that disrupt the synthesis of this disaccharide or the formation of a functional tetramer and the use of cryo-EM in the structural characterization of CnTps1-ligand/drug complexes. | ||||||
History |
|
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Downloads & links
-Download
PDBx/mmCIF format | 8fhw.cif.gz | 563.5 KB | Display | PDBx/mmCIF format |
---|---|---|---|---|
PDB format | pdb8fhw.ent.gz | 461.2 KB | Display | PDB format |
PDBx/mmJSON format | 8fhw.json.gz | Tree view | PDBx/mmJSON format | |
Others | Other downloads |
-Validation report
Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/fh/8fhw ftp://data.pdbj.org/pub/pdb/validation_reports/fh/8fhw | HTTPS FTP |
---|
-Related structure data
Related structure data | 29172MC M: map data used to model this data C: citing same article (ref.) |
---|---|
Similar structure data | Similarity search - Function & homologyF&H Search |
-Links
-Assembly
Deposited unit |
|
---|---|
1 |
|
-Components
#1: Protein | Mass: 76815.500 Da / Num. of mol.: 4 Source method: isolated from a genetically manipulated source Details: UDP G6P Source: (gene. exp.) Cryptococcus neoformans var. grubii H99 (fungus) Gene: CNAG_05292 / Plasmid: pMCSG7 / Production host: Escherichia coli BL21(DE3) (bacteria) / Variant (production host): C41 / References: UniProt: J9VJZ1 #2: Chemical | ChemComp-UDP / #3: Sugar | ChemComp-G6P / Has ligand of interest | Y | |
---|
-Experimental details
-Experiment
Experiment | Method: ELECTRON MICROSCOPY |
---|---|
EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-Sample preparation
Component | Name: Cryo-EM structure of Cryptococcus neoformans trehalose-6-phosphate synthase homotetramer in complex with uridine diphosphate and glucose-6-phosphate Type: COMPLEX / Entity ID: #1 / Source: RECOMBINANT |
---|---|
Molecular weight | Value: 0.307 MDa / Experimental value: YES |
Source (natural) | Organism: Cryptococcus neoformans var. grubii H99 (fungus) |
Source (recombinant) | Organism: Escherichia coli (E. coli) / Strain: C41(DE3) / Plasmid: pMCSG7 |
Buffer solution | pH: 7.5 |
Specimen | Conc.: 0.75 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES |
Vitrification | Cryogen name: ETHANE |
-Electron microscopy imaging
Experimental equipment | Model: Titan Krios / Image courtesy: FEI Company |
---|---|
Microscopy | Model: FEI TITAN KRIOS |
Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: OTHER |
Electron lens | Mode: BRIGHT FIELDBright-field microscopy / Nominal defocus max: 2500 nm / Nominal defocus min: 800 nm |
Image recording | Electron dose: 60 e/Å2 / Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) |
-Processing
CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3D reconstruction | Resolution: 3.2 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 854608 / Symmetry type: POINT | ||||||||||||||||||||||||
Refinement | Cross valid method: NONE Stereochemistry target values: GeoStd + Monomer Library + CDL v1.2 | ||||||||||||||||||||||||
Displacement parameters | Biso mean: 48.64 Å2 | ||||||||||||||||||||||||
Refine LS restraints |
|